首页> 外文期刊>Iranian Journal Of Allergy, Asthma and Immunology >The Efficacy of Oral Immunotherapy in Patients with Cow's Milk Allergy
【24h】

The Efficacy of Oral Immunotherapy in Patients with Cow's Milk Allergy

机译:牛奶过敏患者口服免疫治疗的疗效

获取原文
           

摘要

Cow's milk allergy is the most common type of food allergy that decrease the quality of life of patients and their families. The aim of this study was to evaluate the efficacy of oral immunotherapy in patients with cow's milk allergy. 14 patients above 3 years of age with a history of cow's milk allergy confirmed by positive double blind placebo controlled food challenge (DBPCFC) test, presence of serum IgE against cow's milk and positive SPT (skin prick test) were enrolled in this study. During the immunotherapy all patients received increasing amounts of cow's milk during three phases. The type and severity of allergic reactions were recorded after each dose. The serum IgE and SPT were measured at the beginning and at the end of study.?Since February 2014 to March 2015, 14 patients with the median age of 4.75 (3.7-7) years were studied. 13 patients (92.9%) completed the build up and maintenance phase successfully and became desensitized to cow's milk. During the build up and maintenance phase, 24 (2.0%) and 11 (0.9%) episodes of allergic reactions occurred, respectively.?The median serum IgE level against cow's milk proteins and casein decreased from 39.3 to 10.4 and 7.72 to 2.83 (ku/L), respectively. The median of the difference of the wheal diameter in SPT with the control, decreased from 10 to 6 mm during the immunotherapy protocol.?Oral immunotherapy is effective to decrease the frequency and the severity of allergic reactions but due to high rate of allergic reactions and possible anaphylaxis, it must be done under strict supervision of both clinicians and caregivers.
机译:牛奶过敏是最常见的食物过敏类型,会降低患者及其家人的生活质量。本研究的目的是评估口服免疫疗法对牛奶过敏患者的疗效。这项研究招募了14名3岁以上,具有牛奶过敏史的患者,该患者已通过阳性双盲安慰剂对照食物激发试验(DBPCFC)测试,存在针对牛奶的血清IgE和阳性SPT(皮肤点刺试验)证实。在免疫治疗期间,所有患者在三个阶段中都接受了越来越多的牛奶。每次服药后记录过敏反应的类型和严重程度。在研究开始和结束时测量血清IgE和SPT。自2014年2月至2015年3月,研究了14位中位年龄为4.75(3.7-7)岁的患者。 13名患者(92.9%)成功完成了建立和维持阶段,并对牛奶不敏感。在建立和维持阶段,分别发生了24次(2.0%)和11次(0.9%)过敏反应。抵抗牛奶蛋白和酪蛋白的血清IgE中位值从39.3降至10.4和7.72降至2.83(ku / L)。在免疫治疗方案中,SPT中的风团直径差异与中值的中位数从10毫米减小到6毫米。口服免疫疗法可有效降低过敏反应的频率和严重性,但由于过敏反应和可能的过敏反应,必须在临床医生和护理人员的严格监督下进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号